Shantha Biotechnics Pvt. Ltd. Sustainability Profile
Shantha Biotechnics Pvt. Ltd., a prominent player in the biopharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1993, the company has made significant strides in the development and production of vaccines and biopharmaceuticals, focusing on innovative solutions for public health challenges. Renowned for its pioneering work in recombinant DNA technology, Shantha Biotechnics offers a range of core products, including vaccines for hepatitis B and typhoid, which are distinguished by their affordability and accessibility. The company has achieved notable milestones, including regulatory approvals and partnerships that enhance its market position. With a commitment to quality and innovation, Shantha Biotechnics continues to contribute significantly to the global healthcare landscape.
DitchCarbon Score
How does Shantha Biotechnics Pvt. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shantha Biotechnics Pvt. Ltd.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shantha Biotechnics Pvt. Ltd., headquartered in India, currently does not have specific carbon emissions data available for the most recent year. However, the company is a current subsidiary of Sanofi, which influences its climate commitments and emissions reporting. As part of its corporate family relationship with Sanofi, Shantha Biotechnics adheres to various climate initiatives and targets cascaded from its parent company. These include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are aimed at reducing carbon emissions and promoting sustainability. While specific reduction targets for Shantha Biotechnics are not detailed, the overarching goals set by Sanofi reflect a commitment to significant emissions reductions across its operations. This includes a focus on Scope 1, 2, and 3 emissions, although specific figures for Shantha Biotechnics are not disclosed. In summary, while Shantha Biotechnics Pvt. Ltd. does not provide specific emissions data or reduction targets, it is aligned with the climate commitments of its parent company, Sanofi, which actively engages in initiatives to mitigate climate impact and promote sustainability within the biopharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 545,114,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 677,549,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Shantha Biotechnics Pvt. Ltd.'s Industry?
How Carbon Intensive is Shantha Biotechnics Pvt. Ltd.'s Location?
Shantha Biotechnics Pvt. Ltd.'s Scope 3 Categories Breakdown
Shantha Biotechnics Pvt. Ltd.'s Scope 3 emissions, which decreased by 5% last year and increased by approximately 40% since 2013, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 69% of Scope 3 emissions.
Top Scope 3 Categories
Shantha Biotechnics Pvt. Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shantha Biotechnics Pvt. Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
